Valsartan — Discount Pricing
Valsartan is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Valsartan Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $30.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Valsartan
Valsartan is a prescription medication. Ask your doctor if Valsartan is right for you.
Conditions Treated with Valsartan
How to Check Valsartan Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Valsartan at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Related medications
Other medications associated with the same conditions in this catalog.
Also listed for Hypertension
Other medications in Heart & Cardiovascular
What Valsartan is approved for (FDA label)
Valsartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension , to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of heart failure (NYHA class II-IV); valsartan tablets significantly reduced hospitalization for heart failure. ( 1.2 ) Post-myocardial infarction; for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction. ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the treatment of hypertension, to lower blood pressure in adults and pediatric patients six years of age and older.
Source: Read the full FDA label on DailyMed. Label effective date: September 2, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Boxed warning for Valsartan (FDA label)
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue valsartan tablets as soon as possible. (5.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1) WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue valsartan tablets as soon as possible. ( 5.1 ) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. ( 5.1 )
Source: FDA prescribing information (DailyMed). Set ID: 5a816ea6-2645-bd6e-e063-6294a90a908b. SPL document ID: 5a816ba8-afd9-bda3-e063-6294a90a16bb. Label effective date: September 2, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Valsartan (FDA label)
40 mg are yellow, oval, film-coated scored tablets debossed with ”3” bisect “7” on one side and “AN” on the other side. 80 mg are pink, oval, film-coated tablets with beveled edges, debossed with ”838” on one side and ”AN” on the other side. 160 mg are yellow, oval, film-coated tablets with beveled edges, debossed with ”839” on one side and “AN” on the other side. 320 mg are brown, oval, film-coated tablets with beveled edges, debossed with ”840” on one side and “AN” on the other side. Tablets (mg): 40 (scored), 80, 160, 320
Source: FDA prescribing information (DailyMed). Set ID: 5a816ea6-2645-bd6e-e063-6294a90a908b. SPL document ID: 5a816ba8-afd9-bda3-e063-6294a90a16bb. Label effective date: September 2, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Valsartan (FDA label)
Hypertension: Most common adverse reactions are headache, dizziness, viral infection, fatigue and abdominal pain. (6.1) Heart Failure: Most common adverse reactions are dizziness, hypotension, diarrhea, arthralgia, back pain, fatigue and hyperkalemia. (6.1) Post-Myocardial Infarction: Most common adverse reactions which caused patients to discontinue therapy are hypotension, cough and increased blood creatinine. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact AvKARE at 1-855-361-3993 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Studies Experience Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
Source: FDA prescribing information (DailyMed). Set ID: 5a816ea6-2645-bd6e-e063-6294a90a908b. SPL document ID: 5a816ba8-afd9-bda3-e063-6294a90a16bb. Label effective date: September 2, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Valsartan (FDA label)
Do not use in patients with known hypersensitivity to any component. Do not co-administer aliskiren with valsartan tablets in patients with diabetes [see Drug Interactions (7) ] . Known hypersensitivity to any component. Do not co-administer aliskiren with valsartan tablets in patients with diabetes. (4)
Source: FDA prescribing information (DailyMed). Set ID: 5a816ea6-2645-bd6e-e063-6294a90a908b. SPL document ID: 5a816ba8-afd9-bda3-e063-6294a90a16bb. Label effective date: September 2, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.